McKesson Stock News

McKesson Corporation (MCK) shares up 138.5% since Big Money bought big in May 2022.

McKesson Corporation (NYSE:MCK ) Analyst/Investor Day September 23, 2025 9:30 AM EDT Company Participants Brian Tyler - CEO & Director Britt Vitalone - Executive VP & CFO Kirk Kaminsky - President of The US Pharmaceutical & Specialty Solutions Business Joan Eliasek - President Jason Hammonds Kevin Kettler Conference Call Participants Lisa Gill - JPMorgan Chase & Co, Research Division George Hil...

McKesson on Tuesday raised its profit forecast, as the U.S. drug distributor aims to focus on high-margin businesses such as cancer medicines to boost growth.

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will host its 2025 Investor Day today, beginning at 9:30 AM ET. During the event, executive leadership will discuss the company's multi-year strategic priorities, growth strategies, and long-term business outlook. The Investor Day event will showcase how McKesson continues to accelerate long-term growth and deliver sustained value...

McKesson said on Thursday it will restructure its operations into four main segments from the current quarter as the U.S. drug distributor aims to focus on high-margin businesses such as cancer medicines to boost growth.

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) today announced changes to its reportable segments and organizational structure, effective in the second quarter of fiscal year 2026. The new reporting structure enhances strategic alignment and transparency, supporting optimizing portfolio management to drive sustainable long-term value creation for shareholders. “McKesson has a ...

McKesson Corporation (NYSE:MCK ) Q1 2026 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Brian S. Tyler - CEO & Director Britt J.

U.S. drug distributor McKesson raised its annual profit forecast and beat Wall Street earnings estimates on Wednesday, banking on robust demand for specialty medicines.